Terpene Rich Formulations For Symptom-Specific Care
Dr. Rick Weyback, Neurologist & Certified Oblend Physician, ComCan Healthcare, LLC
The beneficial effects of CBD from hemp and THC from marijuana are well-documented and are recognized for their potential to address a variety of medical conditions. The roles of other cannabinoids such as CBG and CBN, and of terpenes derived from cannabis or from botanical sources, are not as well understood or documented. This presentation describes the use of specific combinations of cannabinoids and terpenes to address various medical conditions, the potential of personalized cannabis formulations in patient care, and clinical observations on the use of personalized formulations to address specific conditions.
Dr. Weyback, a US Navy veteran, is a neurologist and a Certified Oblend physician currently practicing as a cannabis specialist with ComCan Healthcare, a medical marijuana clinic with locations in Delray Beach and Wellington, Florida. Dr. Weyback has made it his mission to bring education and evidence-based personalized therapy to his patients.
In 2021, Dr. Weyback, along with Dr. Mitch Davis, a gastroenterologist and ComCan’s Chief Medical Officer, received their Oblend Certification. Using Oblend’s platform, ComCan has recommended personalized, consistent Oblend formulations to over 100 patients, and, based on patient feedback, recommended adjustments to the formulations, including changes to individual cannabinoid & terpenoid amounts, to provide patients with the perfect, personalized Oblend formulation that addresses each patient’s unique needs.
As a member of the Brigade of Midshipmen of the United States Naval Academy, Dr. Weyback played Division-I men’s ice hockey as a highly recruited defenseman. Dr. Weyback is passionate about ensuring that first responders and veterans have access to the benefits of medical cannabis they can use to manage the psychological and physical conditions that disproportionately affect them.
Dr. Weyback served as Chair of the Board of Editors of the Journal of Cannabinoid Medicine. He has co-authored a number of peer-reviewed medical articles, including "The Aging Brain: The Significance of the Default Mode Network (DMN) in Neurological and Neuropsychiatric Disorders: A Review,” in the Yale Journal of Biology and Medicine; “Caffeine as Treatment for Alzheimer’s Disease: A Review,” in the Journal of Caffeine Research; and “The Positive Correlation Between Migraine and Vertigo: A Review,” in The Egyptian Journal of Otolaryngology.” Dr. Weyback holds dual Bachelor of Science degrees in Chemistry and Biology and a Post-Baccalaureate in Medical Sciences from the University of Pennsylvania. He obtained his Doctor of Medicine from Eastern Virginia Medical School in 2014, received his residency training at the Medical University of South Carolina, and is a member of the Congress of Neurological Surgeons, American Association of Neurological Surgeons, North American Spine Society, and the Florida Medical Association. Currently, he is one of the first physicians in the world pursuing a Master of Science degree in Medical Cannabis Science and Therapeutics from the University of Maryland School of Pharmacy. Additionally, he is an Athlete Ambassador for Athletes for Care, a nonprofit organization started by and for professional, Olympic, and collegiate level athletes with a focus on advocacy on traumatic brain injury and cannabis use as a medical therapy. Dr. Weyback currently resides in Palm Beach County, FL with his wife, and their daughter.